Issue 1 · June 25, 2026 · 5 min read
Your Generation May Be Aging Faster Than the Last
A 154,000-person study on why younger adults test biologically older
Aging used to be a number you got on a birthday. This week it became something scientists can measure cell by cell, and a 154,000-person study found a catch: younger generations are testing biologically older than their parents did at the same age. Here's what's worth knowing:
Aging, cell by cell: A new Stanford blood test read the age of 40-plus cell types from a single draw in 60,542 people, and those cell-by-cell ages predicted disease and death up to 15 years out.
COVID ages you: A new immune-system aging clock found that COVID-19 leaves the immune system looking measurably older, though the study was small and still needs wider testing.
Clearing zombie cells: The senolytic combo dasatinib and quercetin rebooted the worn-out tissues of aged mice, working best when started early, but it's still mouse-only.
Lifestyle still wins: Twenty-one years on, the landmark diabetes-prevention trial found a lifestyle program cut the risk of piling up chronic diseases by 21%, while metformin alone didn't budge it.
Move more, not less: The first big tracker study found people on GLP-1s walked about 560 fewer steps a day after starting, a reminder to guard your muscle while the weight comes off.
Glucose without a doctor: Ultrahuman put Abbott's over-the-counter glucose monitor on a $99-a-month plan with no prescription, making continuous blood sugar one of the easier biomarkers to start tracking.
Rapamycin hits the shelf: Rapalogix raised $20 million to put rapamycin, one of the longevity world's most-studied drugs, into skin care, an early sign that lab favorites are racing toward the bathroom cabinet.
Body scans go spa-casual: The AI-image company Midjourney teased a 60-second whole-body scanner and a 2027 "longevity spa," betting health imaging can feel as routine as a sauna day, though it's still a concept, not a cleared device.
Better, not just longer: Some good news: Americans at 65 are spending about 30% less time disabled at the end of life than a generation ago, even as they live longer.
The Ozempic-face trade-off: Rapid GLP-1 weight loss is hollowing cheeks and sending Gen X to the facelift table a decade early, with surgeons reporting a 50% jump in fat-grafting.
The $818 billion bill: A new estimate put the 2026 U.S. cost of dementia at about $818 billion, most of it the unpaid hours families spend on care, a reminder that protecting the brain is economic as much as personal.
Check the source: Bryan Johnson is taking the ED drug Cialis daily as a longevity play, citing 34% lower mortality, but that figure traces to a 2024 observational study that only shows correlation, not proof.
⭐ Featured
Your generation may be aging faster than the last
Scientists can now score your "biological age" from a blood sample, separate from the candles on your cake. A big new Nature Medicine study used that to compare generations, and the result is a wake-up call:
The trend: across 154,000 U.K. adults, each younger generation scored biologically older than the last, those born in the late 1960s aging faster than those born in the early 1950s.
The catch: a wider gap between biological and actual age tracked with higher odds of early-onset cancer, the kind increasingly showing up in people under 50.
The fine print: it's an association, not proof, and the generational gap is small, a fraction of a standard deviation.
The honest read: it's a correlation from one big database, and these clocks are still maturing. But it fits a rise doctors keep flagging, and it argues for watching your biological age now, not at 65.
The empowering part: biological age, unlike your birthday, can move. The biomarkers you can already track are where it starts.
📌 Also worth your time
❤️ An AI that sees the heart risk your EKG misses
Researchers at UC Berkeley trained a model on more than 440,000 ECGs and found a hidden high-risk group: about 2% of people whose heart tracings looked unremarkable to the standard test, yet who faced a 7%-a-year risk of sudden cardiac death. Strikingly, 86% of them would have been missed by today's main screening tool.
The hopeful part: high-risk patients who already had defibrillators were far less likely to die than expected, which suggests the model is pointing to people a simple device could protect. It's still an early, research-stage tool built on past records, not something your cardiologist offers tomorrow. But it's a glimpse of medicine catching quiet, deadly risk early, which is the whole game. Knowing your own numbers is step one.
💉 A shingles shot that may protect your brain
Older adults who got the Shingrix shingles vaccine had about 24% less dementia over four years, in a study of more than half a million people. In plain terms, dementia showed up in about 19% of the vaccinated versus 25% of those who skipped the shot, echoing a growing list of findings that tie this particular vaccine to a healthier brain.
The caveat matters: this compared people who chose the vaccine to those who didn't, so healthier habits could explain part of the gap, and it can't prove the shot itself did the work. Still, it's a low-risk vaccine most older adults are already advised to get, now with a possible bonus. If you're 50 or older, a telehealth clinician can walk you through timing.
📅 On the radar
Mark July 1: the new Medicare GLP-1 Bridge opens, letting eligible Medicare members get drugs like Wegovy and Zepbound for $50 a month through 2027. CVS says it will take part across 9,000-plus pharmacies and is adding a $49 virtual weight-loss visit for everyone else. You'll have to qualify, and the $50 won't count toward your yearly out-of-pocket cap, but it's the widest Medicare door to these drugs yet.
Go deeper at longevity.io